Computable features required to evaluate the efficacy of drugs and a universal algorithm to find optimally effective drug in a drug complex.
<h4>Background</h4>The H1N1 pandemic in 2009 and the H5N1 pandemic in 2005 demonstrated that the drugs approved to treat influenza A viruses have low efficacy. This provided a stimulus for new studies of influenza A viruses in the context of the methods used in drug design developed over...
Enregistré dans:
Auteurs principaux: | Kui Wang, Wei Cui, Gang Hu, Jianzhao Gao, Zhonghua Wu, Xingye Qiu, Jishou Ruan, Yi Feng, Zhi Qi, Yiming Shao, Jack A Tuszynski |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d70c114404bf4ed28d24eceebff12f76 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The molecular mechanism of action of the CR6261-Azichromycin combination found through computational analysis.
par: Wei Cui, et autres
Publié: (2012) -
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings.
par: Monica Puligheddu, et autres
Publié: (2013) -
Machine Learning-Based Prediction of Drug-Drug Interactions for Histamine Antagonist Using Hybrid Chemical Features
par: Luong Huu Dang, et autres
Publié: (2021) -
Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro.
par: Rui-Rui Wang, et autres
Publié: (2014) -
Drugs
Publié: (1971)